Introduction: The incidence of stroke increases exponentially with age, representing the leading cause of death after the 80 years of age. Intravenous thrombolysis with recombinant tissue plasminogen activator (IV-rtPA) represents an advance in the treatment of ischemic stroke and its use in the elderly > 80 years old was a recent target of discussion.Material and Methods: A retrospective study was performed...